Research Article
The Predictive Role of Parathyroid Hormone for Nonalcoholic Fatty Liver Disease following Bariatric Surgery
Table 3
Liver status and PTH level in clinically severe obese patients before and after bariatric surgery.
| Variable | Before | After | P value |
| Liver stiffness measurement (kPa) | 6.1 ± 1.25 | 5.42 ± 1.52 | 0.002 | AST (IU/L) | 23.60 ± 10.48 | 22.26 ± 12.93 | 0.382 | ALT (IU/L) | 26.69 ± 19.30 | 19.92 ± 11.79 | <0.001 | GGT (IU/L) | 31.62 ± 20.21 | 20.63 ± 24.79 | <0.001 | ALP (IU/L) | 196.25 ± 53.79 | 222.50 ± 65.61 | <0.001 | FIB-4 | 0.59 ± 0.26 | 0.57 ± 0.40 | 0.123 | NFS | −1.42 ± 1.21 | −2.26 ± 1.25 | <0.001 | Steatosis (ultrasonography) | | | <0.001 | Grade 0 | 5 (5.5) | 16 (18) | | Grade 1 | 19 (21.1) | 47 (52.8) | | Grade 2 | 53 (58.8) | 24 (27) | | Grade 3 | 13 (14.4) | 2 (2.2) | | PTH (pg/mL) | 47.88 ± 24.22 | 45.44 ± 25.94 | 0.464 |
|
|
Data mentioned in N (%), mean ± SD; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline transferase; GGT, gamma-glutamyl transferase; FIB-4, fibrosis 4; NFS, NAFLD fibrosis score; PTH, parathyroid hormone.
|